Mannitol Use in Hemodialysis Patients: Risks and Monitoring

Pharmacological Considerations

• Mannitol can cause significant fluid and electrolyte imbalances, particularly hypernatremia due to free water loss exceeding sodium loss, in patients with impaired renal function 1
• Electrolyte abnormalities, including hypernatremia, require close monitoring in hemodialysis patients receiving mannitol 2

Monitoring and Management

• Serum electrolytes, particularly sodium and potassium, should be closely monitored in hemodialysis patients receiving mannitol 2
• Serum osmolality should be maintained below 320 mOsm/L during mannitol therapy to minimize the risk of toxicity 1

Alternative Therapies

• For volume management in hemodialysis patients, appropriate ultrafiltration techniques and dietary sodium restriction are preferred over mannitol, as recommended by the American Journal of Kidney Diseases 3, 4
• Hypertonic saline may be considered as an alternative to mannitol for management of intracranial hypertension, with a different side effect profile 1

Contraindications and Precautions

• The American Heart Association, as published in Circulation, advises against using mannitol solely for the purpose of renal protection 5, 6